Influenza vaccination for immunocompromised patients: Summary of a systematic review and meta-analysis

Influenza and other Respiratory Viruses

Volumn 7, Issue SUPPL.2, 2013, Pages 72-75

  Beck, Charles R ^a   Mckenzie, Bruce C ^a   Hashim, Ahmed B ^a   Harris, Rebecca C ^b   Zanuzdana, Arina ^c   Agboado, Gabriel ^d   Orton, Elizabeth ^a   Béchard Evans, Laura ^b   Morgan, Gemma ^e   Stevenson, Charlotte ^e   Weston, Rachel ^e   Mukaigawara, Mitsuru ^b   Enstone, Joanne ^a   Augustine, Glenda ^f   Butt, Mobasher ^g   Kim, Sophie ^h   Puleston, Richard ^a   Dabke, Girija ^e   Howard, Robert ⁱ   O'Boyle, Julie ⁱ   O'Brien, Mary ^j   Ahyow, Lauren ^f   Denness, Helene ^k   Farmer, Siobhan ^l   Figureroa, Jose ^m   Fisher, Paul ⁿ   Greaves, Felix ^o   Haroon, Munib ^p   Haroon, Sophie ^e   Hird, Caroline ^e   Isba, Rachel ^q   Ishola, David A ^r   Kerac, Marko ^r   Parish, Vivienne ^s   Roberts, Jonathan ^e   Rosser, Julia ^t   Theaker, Sarah ^u   Wallace, Dean ^u   Wigglesworth, Neil ^v   Lingard, Liz ^e   Vinogradova, Yana ^a   Horiuchi, Hiroshi ^w   Peñalver, Javier ^b   Nguyen Van Tam, Jonathan S ^a   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c BIELEFELD UNIVERSITY   (Germany)

^d NHS Blackpool   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f Leicestershire Health   (United Kingdom)

^g UK   (United Kingdom)

^h HARVARD LAW SCHOOL   (United States)

ⁱ Public Health Nottingham City Council   (United Kingdom)

^j Public Health   (United Kingdom)

^k NHS Derbyshire County   (United Kingdom)

^l Public Health   (United Kingdom)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ Solihull NHS Primary Care Trust   (United Kingdom)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p Leicester Partnership Trust   (United Kingdom)

^q LANCASTER UNIVERSITY   (United Kingdom)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s Public Health   (United Kingdom)

^t Public Health Directorate   (United Kingdom)

^u Public Health Directorate   (United Kingdom)

^v NHS East Lancashire   (United Kingdom)

^w TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

more..

Author keywords

Immunocompromised; Influenza; Meta analysis; Systematic review; Vaccination

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE;

ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; DATA BASE; DATA EXTRACTION; HEALTH CARE; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA VACCINATION; META ANALYSIS; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PATIENT SAFETY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEASONAL INFLUENZA; SEROCONVERSION; SEROLOGY; SYSTEMATIC REVIEW;

IMMUNOCOMPROMISED; INFLUENZA; META-ANALYSIS; SYSTEMATIC REVIEW; VACCINATION;

ANTIBODIES, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84883197971     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12084     Document Type: Article

References (11)

1. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9:493-504.
2. Chapter 19 influenza: updated 24 August 2012. Available at http://immunisation.dh.gov.uk/green-book-chapters/chapter-19 (Accessed 11 December 2012).
3. Ring A, Marx G, Steer C, Harper P. Influenza vaccination and chemotherapy: a shot in the dark? Support Care Cancer 2002; 10:462-465.
4. Goossen GM, Kremer LCM, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev 2009; CD006484. Available at: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006484.pub2/pdf.
5. Atashili J, Kalilani L, Adimora AA. Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis 2006; 6:138.
6. Anema A, Mills E, Montaner J, Brownstein JS, Cooper C. Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis. HIV Med 2008; 9:57-61.
7. Beck CR, McKenzie BC, Hashim AB et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS ONE 2011; 6:e29249.
8. Beck CR, McKenzie BC, Hashim AB, Harris RC. University of Nottingham Influenza and the ImmunoCompromised (UNIIC) Study Group, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis 2012; 206:1250-1259.
9. Beck C, McKenzie B, Hashim A, Nguyen-Van-Tam J. Clinical effectiveness of influenza vaccination for immunocompromised patients: a systematic review and meta-analysis. PROSPERO: International prospective register of systematic reviews 2011:CRD42011001226. Available at: http://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42011001226 (Accessed 11 December 2012).
10. World Health Organization. WHO guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. Part I Recommendations. World Health Organization 2010.
11. Committee for Proprietary Medicinal Products. Note for Guidance on Harmonisation of Requirements for Influenza Vaccines. CPMP/BWP/214/96. London: European Agency for the Evaluation of Medicinal Products, 1997.